PT2934506T - Derivados de glutamato para utilização tópica como princípio ativo imunomodulador - Google Patents

Derivados de glutamato para utilização tópica como princípio ativo imunomodulador

Info

Publication number
PT2934506T
PT2934506T PT138115134T PT13811513T PT2934506T PT 2934506 T PT2934506 T PT 2934506T PT 138115134 T PT138115134 T PT 138115134T PT 13811513 T PT13811513 T PT 13811513T PT 2934506 T PT2934506 T PT 2934506T
Authority
PT
Portugal
Prior art keywords
active ingredient
topical use
glutamate derivatives
immunomodulatory active
immunomodulatory
Prior art date
Application number
PT138115134T
Other languages
English (en)
Inventor
Redoules Daniel
Daunes-Marion Sylvie
Poigny Stéphane
Aries Marie-Françoise
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of PT2934506T publication Critical patent/PT2934506T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT138115134T 2012-12-19 2013-12-19 Derivados de glutamato para utilização tópica como princípio ativo imunomodulador PT2934506T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1262329A FR2999573B1 (fr) 2012-12-19 2012-12-19 Derives de glutamate pour leur utilisation topique en tant que principe actif immunomodulateur

Publications (1)

Publication Number Publication Date
PT2934506T true PT2934506T (pt) 2018-04-20

Family

ID=48468413

Family Applications (1)

Application Number Title Priority Date Filing Date
PT138115134T PT2934506T (pt) 2012-12-19 2013-12-19 Derivados de glutamato para utilização tópica como princípio ativo imunomodulador

Country Status (10)

Country Link
US (1) US9493401B2 (pt)
EP (1) EP2934506B1 (pt)
JP (1) JP6381544B2 (pt)
AR (1) AR094189A1 (pt)
DK (1) DK2934506T3 (pt)
ES (1) ES2665364T3 (pt)
FR (1) FR2999573B1 (pt)
NO (1) NO2934506T3 (pt)
PT (1) PT2934506T (pt)
WO (1) WO2014096155A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128181C (pt) 1964-01-06
GB1125820A (en) * 1965-12-24 1968-09-05 Kyowa Hakko Kogyo Company Ltd The uses of glutamic acid derivatives as preservatives
JPS4928269B1 (pt) * 1969-09-30 1974-07-25
JPS5238092B1 (pt) * 1971-01-23 1977-09-27
GB9210756D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition

Also Published As

Publication number Publication date
JP2016508974A (ja) 2016-03-24
EP2934506B1 (fr) 2018-01-17
NO2934506T3 (pt) 2018-06-16
ES2665364T3 (es) 2018-04-25
FR2999573B1 (fr) 2016-01-01
JP6381544B2 (ja) 2018-08-29
DK2934506T3 (en) 2018-04-30
US20160060208A1 (en) 2016-03-03
FR2999573A1 (fr) 2014-06-20
EP2934506A1 (fr) 2015-10-28
AR094189A1 (es) 2015-07-15
WO2014096155A1 (fr) 2014-06-26
US9493401B2 (en) 2016-11-15

Similar Documents

Publication Publication Date Title
HK1207294A1 (en) Topical non-aqueous pharmaceutical formulations
IL238713A0 (en) Self-regulating active pharmaceutical ingredient release
EP2931730A4 (en) 4-PYRIDINONETRIAZINE DERIVATIVES AS INHIBITORS OF HIV INTEGRASE
HK1193813A1 (zh) 藥學活性的二取代的吡啶衍生物
EP2746283A4 (en) PYRIMIDOPYRIMIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES
DK2900645T3 (da) Herbicidt aktive 3-phenylisoxazolinderivater
IL235425B (en) History of lysine-glutamic acid di-peptide
EP2804606A4 (en) TOPICAL THERAPEUTIC FORMULATIONS
EP2870140B8 (en) Tetrahydroquinazolinone derivatives as parp inhibitors
EP2877469A4 (en) SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS INHIBITORS OF HIV INTEGRASE
DK2931720T3 (da) Faststofdispersion med forbedret opløselighed omfattende tetrazolderivat som aktiv bestanddel
HK1205146A1 (en) Pharmaceutical formulation
ZA201306643B (en) Formulation comprising phenylaminopyrimidine derivatives as active agent
EP2864328B8 (en) Pharmaceutically active compounds
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
HK1207296A1 (en) Genotype- or phenotype-based drug formulation
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
PT2934506T (pt) Derivados de glutamato para utilização tópica como princípio ativo imunomodulador
GB201204597D0 (en) Topical pharmaceutical formulation
GB201222922D0 (en) Topical formulation
GB201110027D0 (en) Topical formulation
GB201110030D0 (en) Topical formulation
EP2738174A4 (en) NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT